Dr Tara Heitner Appointed New CEO for Cyxone

STOCKHOLM, May 20, 2020 -- (Healthcare Sales & Marketing Network) -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that Tara Heitner PhD MBA has been appointed new CEO for the company by Board of Directors. Dr Heitner brings ... Biopharmaceuticals, Personnel Cyxone, multiple sclerosis, rheumatoid arthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news